Pharmacovigilance

As per available reports about 45 Journals, 15 Conferences are presently dedicated exclusively to Pharmacovigilance and about 6364 articles are being published on the current trends in Pharmacovigilance. In terms of research annually, USA, India, Japan, Brazil and Canada are some of the leading countries where maximum studies related to pharmacovigilance is apprehensive with identifying the hazards linked with pharmaceutical commodities and with minimizing the hazard of any damage that may approach patients.

Pharmacovigilance has its own exclusive expression that is significant to realize. Most of the following terms used are peculiar to drug protection, although a few are used by other disciplines within the pharmaceutical science also. The action that is mainly commonly related with Pharmacovigilance (PV), and which consumes a major quantity of resources for drug regulatory authorities (or similar government agencies) and drug safety departments in pharmaceutical companies, is that of adverse event reporting.

The Journal of Pharmacovigilance is an open access journal – hosted by OMICS International – a initiate in open access publishing–and is listed among the top 10 journals in Pharmacovigilance researches.

Journal of Pharmacovigilance is about the pharmaceutical interference, defence, side effects and adverse effects as well as medications toxicity. Unintentional effects are common yet often times there is short of qualitative and quantitative statistics that allows for a precise estimation of the risk/benefits profile of pharmaceuticals. Advances in biomedical science have generated more new and complex medicines to treat a broader variety of diseases and conditions than ever before.